Polyurethane having an antithrombogenic coating
Assigneepfm medical titanium gmbh
InventorsKarin Stadtherr, Christof Schmid, Karla Lehle, Karin Lukas, Hanngörg Zimmermann, Daniel Wehner, Thomas Schmid
Life of this patent
Estimating the term…
Loading patent…
Assigneepfm medical titanium gmbh
InventorsKarin Stadtherr, Christof Schmid, Karla Lehle, Karin Lukas, Hanngörg Zimmermann, Daniel Wehner, Thomas Schmid
Estimating the term…
The invention concerns polyurethane (PUR) having an antithrombogenic coating, wherein the antithrombogenic coating comprises at least one antithrombogenic substance covalently bound to a surface of the PUR via at least two bonds, wherein a first of said bonds is an amide bond between the surface of the PUR and a polyethyleneimine (PEI) and a second of said bonds is between the PEI and the antithrombogenic substance, wherein the surface of the PUR had been activated by use of a carbon dioxide plasma or a plasma modified by addition of carbon dioxide before the first of said bonds was formed.
An antithrombogenic polyurethane (PUR) having an antithrombogenic coating, wherein the antithrombogenic coating comprises at least one antithrombogenic substance covalently bound to a surface of the PUR via at least two bonds, wherein a first of said bonds is an amide bond between the surface of the PUR and a polyethyleneimine (PEI) and a second of said bonds is between the PEI and the antithrombogenic substance, wherein the surface of the PUR had been activated by use of a carbon dioxide plasma or a plasma modified by addition of carbon dioxide before the first of said bonds was formed.
A method of producing an antithrombogenic polyurethane (PUR) comprising the following steps:
Dependencies are inferred from the claim text.